சுமன் காந்த் முஞ்சல் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from சுமன் காந்த் முஞ்சல். Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In சுமன் காந்த் முஞ்சல் Today - Breaking & Trending Today

Early-stage VC Inflexor Ventures raises Rs 600-crore fund

Early-stage VC Inflexor Ventures raises Rs 600-crore fund
SECTIONS
Share
Synopsis
SBICAP Ventures, SIDBI by way of its Fund of Funds come in as institutional limited partners in Inflexor Technology Fund, which also has a green shoe option of Rs 100 crore.
ETtech
Inflexor Ventures joins a bevy of rupee funds that have raised capital from domestic investors in the recent past. (Illustration: Rahul Awasthi/ETtech)
Mumbai: Early-stage tech-focused venture capital fund Inflexor Ventures has raised Rs 600 crore towards the final close of its new fund, driven by oversubscription from homegrown institutional investors.
The total fundraise has exceeded its initial target of Rs 500 crore and includes a green shoe option of Rs 100 crore, senior fund officials said. ....

Suman Kant Munjal , Jatin Desai , Venkat Vallabhaneni , Fund Of Funds , Inflexor Technology Fund , Inflexor Ventures , Big Data , சுமன் காந்த் முஞ்சல் , ஜடின் தேசாய் , வெங்கட் வல்லபனேனி , நிதி ஆஃப் நிதி , பெரியது தகவல்கள் ,

Pune-based startup Ahammune Biosciences raises funds to develop vitiligo drug

Pune-based startup Ahammune Biosciences raises funds to develop vitiligo drug
Pune-based startup Ahammune Biosciences raises funds to develop vitiligo drug
26 April 2021 | News
The fresh funds raised will be utilized for “first-in-human” studies with Ahammune’s new drug candidate AB1001 for vitiligo
Image credit- shutterstock.com
Pune-based biotech startup company, Ahammune Biosciences has raised an undisclosed amount in a Pre-Series A round led by Ideaspring Capital and Indian Angel Network. Kotak Private Equity, Legacy Assets LLP (Baldota family fund), and Dr. Ajith Kamath (ex-Pfizer) have also participated in the round along with existing investors, including Dr. Anand Deshpande and Suman Kant Munjal. The Company also has Dr. Ganesh Natarajan as an existing investor and has been in receipt of funding grant from Government of India’s body, BIRAC. ....

Suman Kant Munjal , Parul Ganju , Ganesh Natarajan , Anand Deshpande , Ahammune Biosciences , Ajith Kamath , Legacy Assets , Indian Angel Network , Ideaspring Capital , Indian Angel , Kotak Private Equity , Suman Kant , Investigational New Drug , Drug Controller General , சுமன் காந்த் முஞ்சல் , கணேஷ் நடராஜன் , ஆனந்த் தேஷ்பாண்டே , அஜீத் காமத் , மரபு சொத்துக்கள் , இந்தியன் தேவதை வலைப்பின்னல் , இந்தியன் தேவதை , கோட்டக் ப்ரைவேட் பங்கு , சுமன் காந்த் , மருந்து கட்டுப்படுத்தி ஜநரல் ,

Ahammune Biosciences raises Pre-Series A funding from Ideaspring Capital, Indian Angel Network

Ahammune Biosciences raises Pre-Series A funding from Ideaspring Capital, Indian Angel Network
April 26, 2021
, March 26
Pune-based biotech start-up company Ahammune Biosciences has raised an undisclosed amount in a Pre-Series A round led by Ideaspring Capital and Indian Angel Network.
Kotak Private Equity, Legacy Assets LLP (Baldota family fund) and Ajith Kamath (ex-Pfizer) have also participated in the round along with existing investors, including Anand Deshpande and Suman Kant Munjal. The Company also has Ganesh Natarajan as an existing investor and has been in receipt of funding grant from Government of India’s body, BIRAC.
The freshly-infused capital will be used for “first-in-human” studies with Ahammune’s new drug candidate AB1001 for vitiligo. The study will comprise Phase-I safety studies in healthy human volunteers and Phase-II efficacy studies in vitiligo patients. The company will also deploy the funds in building the patent portfolio to ....

Suman Kant Munjal , Parul Ganju , Ganesh Natarajan , Anand Deshpande , Ahammune Biosciences , Ajith Kamath , Legacy Assets , Indian Angel Network , Ideaspring Capital , Indian Angel , Private Equity , Suman Kant , Investigational New Drug , Drug Controller General , Ahammune Biosciences Raises Pre Seriesa Funding From Ideaspring Capital , சுமன் காந்த் முஞ்சல் , கணேஷ் நடராஜன் , ஆனந்த் தேஷ்பாண்டே , அஜீத் காமத் , மரபு சொத்துக்கள் , இந்தியன் தேவதை வலைப்பின்னல் , இந்தியன் தேவதை , ப்ரைவேட் பங்கு , சுமன் காந்த் , மருந்து கட்டுப்படுத்தி ஜநரல் ,

Skyroot Teams Up With Bellatrix For Vikram Launcher Space Taxis Project

Skyroot Teams Up With Bellatrix For Vikram Launcher Space Taxis Project
Share story
This partnership will help Skyroot to enhance its launch capabilities to meet specialised customer requirements
Last year, Skyroot successfully test-fired upper stage rocket engines, Kalam-5 and Raman
Hyderabad-based space tech startup Skyroot Aerospace and Bengaluru-based small satellite maker Bellatrix Aerospace have signed a partnership to share and cross-leverage each company’s technology platforms for space taxi launches by 2023.
The two spacetech startups will work together on an orbital transfer vehicle (OTV) by 2023 using ISRO’s Vikram launch vehicle. Skyroot’s upper stage rocket engine capabilities will be integrated with Bellatrix’s orbital transfer vehicles to transport satellites, cargo or supplies into space. ....

Andhra Pradesh , Suman Kant Munjal , Rohan Muralidhar , Ankit Nagori , Mukesh Bansal , Deepika Padukone , Pawan Kumar Chandana , Naga Bharath Daka , Yashas Karanam , Karsemven Fund , Bellatrix Aerospace , Skyroot Aerospace , Business Standard , Survam Partners , Suman Kant Munjal Family , ஆந்திரா பிரதேஷ் , சுமன் காந்த் முஞ்சல் , ரோஹன் முரளிதர் , அங்கித் நாகோரி , முகேஷ் பன்சால் , தீபிகா படுகோன் , பவன் குமார் சந்தனா , நாகா பாரத் டாக , யாஷச் கரணம் , பெல்லாட்ரிக்ஸ் விண்வெளி , வணிக தரநிலை ,

DeepTech Startup Atomberg Technologies secures Rs 70 crore funding led by A91 Partners

DeepTech Startup Atomberg Technologies secures Rs 70 crore funding led by A91 Partners
Atomberg aiming to use funds raised to strengthen distribution networks and build brand awareness.
TechSamvad
December 10, 2020 10:44:25 IST
Atomberg logo
Energy-efficient smart fans maker Atomberg Technologies has raised Rs 70 crore in Series B funding led by A91 Partners. The round also saw participation from Suman Kant Munjal s family office Survam Partners and Trifecta Capital. With this financing, the startup has raised a total Rs 160 crore till date. It was founded in 2012 by Sibabrata Das and Manoj Kumar Meena.
The Mumbai-based firm plans to use the funds raised to strengthen its distribution networks across all metro and non-metro cities, ramping up its production capacity, and for building brand awareness. The proceeds will also be used to ....

Suman Kant Munjal , Manoj Meena , Manoj Kumar Meena , Abhay Pandey , Sibabrata Das , Atomberg Technologies , Survam Partners , Manoj Kumar , சுமன் காந்த் முஞ்சல் , மனோஜ் மீனா , மனோஜ் குமார் மீனா , மனோஜ் குமார் ,